Maag

Besides BB Biotech, Swiss investor Rudolf Maag , who owns more than 4% of the company's stock, has lent support to Actelion's current board.

Support for Actelion Management Wanes Goran Mijuk 2011

While some large shareholders, such as Swiss investor Rudolf Maag , have publicly backed Actelion's current board, most other big investors, such as Swiss investment firm BB Biotech AG, have remained silent on how they will vote.

Defending his Actelion Strategy Goran Mijuk 2011

The old truck tarpaulins are washed (hence the jumbo washing machines), sorted, cut and assembled here, right in the centre of the Maag Areal (now being sadly but inevitably redeveloped) in the 'happening' part of town in Zurich West.

August 2009 2009

While a few large communities, like Sun Health, may offer to buy your home outright, many more offer financing that covers the cost of living in their developments while your house is on the market, says Steve Maag , director of residential communities at LeadingAge, a Washington-based umbrella organization for senior-related nonprofits.

A Push to Turn 'For Sale' Into 'Sold' Rachel Louise Ensign 2011

The old truck tarpaulins are washed (hence the jumbo washing machines), sorted, cut and assembled here, right in the centre of the Maag Areal (now being sadly but inevitably redeveloped) in the 'happening' part of town in Zurich West.

kitschenette - life in the swiss lane 2009

The old truck tarpaulins are washed (hence the jumbo washing machines), sorted, cut and assembled here, right in the centre of the Maag Areal (now being sadly but inevitably redeveloped) in the 'happening' part of town in Zurich West.

Freitag factory 2009

ISS's verdict stands in sharp contrast to the view of other large Actelion shareholders, such as Swiss investor Rudolf Maag and Swiss investment company BB Biotech AG.

Actelion Suffers Another Setback Goran Mijuk 2011

Actelion has recently received support from large investors such as Switzerland-based BB Biotech AG and Swiss private investor Rudolf Maag.

Actelion Dissenter Confident of Change Likes Its Chances Goran Mijuk 2011

While hedge funds, which control some 20% of the company's capital, are expected to side with Elliott, Actelion has recently won support from large long-time investors such as BB Biotech AG and Swiss investor Rudolf Maag .

Actelion Wins Support in Fight Against Elliott Goran Mijuk 2011

Rudolf Maag , another key shareholder of Actelion with a 4.2% stake, backed the company's management recently in an open letter and criticized Elliott's moves.

Actelion Is Pressured Over Strategy Goran Mijuk 2011